IBDEI2J2 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,40357,1,4,0)
;;=4^D86.84
;;^UTILITY(U,$J,358.3,40357,2)
;;=^5002449
;;^UTILITY(U,$J,358.3,40358,0)
;;=D86.85^^152^2010^42
;;^UTILITY(U,$J,358.3,40358,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40358,1,3,0)
;;=3^Sarcoid Myocarditis
;;^UTILITY(U,$J,358.3,40358,1,4,0)
;;=4^D86.85
;;^UTILITY(U,$J,358.3,40358,2)
;;=^5002450
;;^UTILITY(U,$J,358.3,40359,0)
;;=D86.83^^152^2010^40
;;^UTILITY(U,$J,358.3,40359,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40359,1,3,0)
;;=3^Sarcoid Iridocyclitis
;;^UTILITY(U,$J,358.3,40359,1,4,0)
;;=4^D86.83
;;^UTILITY(U,$J,358.3,40359,2)
;;=^5002448
;;^UTILITY(U,$J,358.3,40360,0)
;;=D84.1^^152^2010^16
;;^UTILITY(U,$J,358.3,40360,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40360,1,3,0)
;;=3^Defects in Complement System
;;^UTILITY(U,$J,358.3,40360,1,4,0)
;;=4^D84.1
;;^UTILITY(U,$J,358.3,40360,2)
;;=^5002439
;;^UTILITY(U,$J,358.3,40361,0)
;;=D81.810^^152^2010^5
;;^UTILITY(U,$J,358.3,40361,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40361,1,3,0)
;;=3^Biotinidase Deficiency
;;^UTILITY(U,$J,358.3,40361,1,4,0)
;;=4^D81.810
;;^UTILITY(U,$J,358.3,40361,2)
;;=^5002422
;;^UTILITY(U,$J,358.3,40362,0)
;;=E88.01^^152^2010^2
;;^UTILITY(U,$J,358.3,40362,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40362,1,3,0)
;;=3^Apha-1 Antitrypsin Deficiency
;;^UTILITY(U,$J,358.3,40362,1,4,0)
;;=4^E88.01
;;^UTILITY(U,$J,358.3,40362,2)
;;=^331442
;;^UTILITY(U,$J,358.3,40363,0)
;;=J09.X1^^152^2010^25
;;^UTILITY(U,$J,358.3,40363,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40363,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
;;^UTILITY(U,$J,358.3,40363,1,4,0)
;;=4^J09.X1
;;^UTILITY(U,$J,358.3,40363,2)
;;=^5008144
;;^UTILITY(U,$J,358.3,40364,0)
;;=J09.X2^^152^2010^26
;;^UTILITY(U,$J,358.3,40364,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40364,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
;;^UTILITY(U,$J,358.3,40364,1,4,0)
;;=4^J09.X2
;;^UTILITY(U,$J,358.3,40364,2)
;;=^5008145
;;^UTILITY(U,$J,358.3,40365,0)
;;=J09.X3^^152^2010^27
;;^UTILITY(U,$J,358.3,40365,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40365,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
;;^UTILITY(U,$J,358.3,40365,1,4,0)
;;=4^J09.X3
;;^UTILITY(U,$J,358.3,40365,2)
;;=^5008146
;;^UTILITY(U,$J,358.3,40366,0)
;;=J09.X9^^152^2010^28
;;^UTILITY(U,$J,358.3,40366,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40366,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
;;^UTILITY(U,$J,358.3,40366,1,4,0)
;;=4^J09.X9
;;^UTILITY(U,$J,358.3,40366,2)
;;=^5008147
;;^UTILITY(U,$J,358.3,40367,0)
;;=J44.9^^152^2010^14
;;^UTILITY(U,$J,358.3,40367,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40367,1,3,0)
;;=3^COPD,Unspec
;;^UTILITY(U,$J,358.3,40367,1,4,0)
;;=4^J44.9
;;^UTILITY(U,$J,358.3,40367,2)
;;=^5008241
;;^UTILITY(U,$J,358.3,40368,0)
;;=J44.1^^152^2010^12
;;^UTILITY(U,$J,358.3,40368,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40368,1,3,0)
;;=3^COPD w/ Acute Exacerbation
;;^UTILITY(U,$J,358.3,40368,1,4,0)
;;=4^J44.1
;;^UTILITY(U,$J,358.3,40368,2)
;;=^5008240
;;^UTILITY(U,$J,358.3,40369,0)
;;=J42.^^152^2010^10
;;^UTILITY(U,$J,358.3,40369,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,40369,1,3,0)
;;=3^Bronchitis,Unspec Chronic
;;^UTILITY(U,$J,358.3,40369,1,4,0)
;;=4^J42.
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2J2 3774 printed Sep 23, 2025@20:05:44 Page 2
IBDEI2J2 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,40357,1,4,0)
+2 ;;=4^D86.84
+3 ;;^UTILITY(U,$J,358.3,40357,2)
+4 ;;=^5002449
+5 ;;^UTILITY(U,$J,358.3,40358,0)
+6 ;;=D86.85^^152^2010^42
+7 ;;^UTILITY(U,$J,358.3,40358,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,40358,1,3,0)
+10 ;;=3^Sarcoid Myocarditis
+11 ;;^UTILITY(U,$J,358.3,40358,1,4,0)
+12 ;;=4^D86.85
+13 ;;^UTILITY(U,$J,358.3,40358,2)
+14 ;;=^5002450
+15 ;;^UTILITY(U,$J,358.3,40359,0)
+16 ;;=D86.83^^152^2010^40
+17 ;;^UTILITY(U,$J,358.3,40359,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,40359,1,3,0)
+20 ;;=3^Sarcoid Iridocyclitis
+21 ;;^UTILITY(U,$J,358.3,40359,1,4,0)
+22 ;;=4^D86.83
+23 ;;^UTILITY(U,$J,358.3,40359,2)
+24 ;;=^5002448
+25 ;;^UTILITY(U,$J,358.3,40360,0)
+26 ;;=D84.1^^152^2010^16
+27 ;;^UTILITY(U,$J,358.3,40360,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,40360,1,3,0)
+30 ;;=3^Defects in Complement System
+31 ;;^UTILITY(U,$J,358.3,40360,1,4,0)
+32 ;;=4^D84.1
+33 ;;^UTILITY(U,$J,358.3,40360,2)
+34 ;;=^5002439
+35 ;;^UTILITY(U,$J,358.3,40361,0)
+36 ;;=D81.810^^152^2010^5
+37 ;;^UTILITY(U,$J,358.3,40361,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,40361,1,3,0)
+40 ;;=3^Biotinidase Deficiency
+41 ;;^UTILITY(U,$J,358.3,40361,1,4,0)
+42 ;;=4^D81.810
+43 ;;^UTILITY(U,$J,358.3,40361,2)
+44 ;;=^5002422
+45 ;;^UTILITY(U,$J,358.3,40362,0)
+46 ;;=E88.01^^152^2010^2
+47 ;;^UTILITY(U,$J,358.3,40362,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,40362,1,3,0)
+50 ;;=3^Apha-1 Antitrypsin Deficiency
+51 ;;^UTILITY(U,$J,358.3,40362,1,4,0)
+52 ;;=4^E88.01
+53 ;;^UTILITY(U,$J,358.3,40362,2)
+54 ;;=^331442
+55 ;;^UTILITY(U,$J,358.3,40363,0)
+56 ;;=J09.X1^^152^2010^25
+57 ;;^UTILITY(U,$J,358.3,40363,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,40363,1,3,0)
+60 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
+61 ;;^UTILITY(U,$J,358.3,40363,1,4,0)
+62 ;;=4^J09.X1
+63 ;;^UTILITY(U,$J,358.3,40363,2)
+64 ;;=^5008144
+65 ;;^UTILITY(U,$J,358.3,40364,0)
+66 ;;=J09.X2^^152^2010^26
+67 ;;^UTILITY(U,$J,358.3,40364,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,40364,1,3,0)
+70 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
+71 ;;^UTILITY(U,$J,358.3,40364,1,4,0)
+72 ;;=4^J09.X2
+73 ;;^UTILITY(U,$J,358.3,40364,2)
+74 ;;=^5008145
+75 ;;^UTILITY(U,$J,358.3,40365,0)
+76 ;;=J09.X3^^152^2010^27
+77 ;;^UTILITY(U,$J,358.3,40365,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,40365,1,3,0)
+80 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
+81 ;;^UTILITY(U,$J,358.3,40365,1,4,0)
+82 ;;=4^J09.X3
+83 ;;^UTILITY(U,$J,358.3,40365,2)
+84 ;;=^5008146
+85 ;;^UTILITY(U,$J,358.3,40366,0)
+86 ;;=J09.X9^^152^2010^28
+87 ;;^UTILITY(U,$J,358.3,40366,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,40366,1,3,0)
+90 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
+91 ;;^UTILITY(U,$J,358.3,40366,1,4,0)
+92 ;;=4^J09.X9
+93 ;;^UTILITY(U,$J,358.3,40366,2)
+94 ;;=^5008147
+95 ;;^UTILITY(U,$J,358.3,40367,0)
+96 ;;=J44.9^^152^2010^14
+97 ;;^UTILITY(U,$J,358.3,40367,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,40367,1,3,0)
+100 ;;=3^COPD,Unspec
+101 ;;^UTILITY(U,$J,358.3,40367,1,4,0)
+102 ;;=4^J44.9
+103 ;;^UTILITY(U,$J,358.3,40367,2)
+104 ;;=^5008241
+105 ;;^UTILITY(U,$J,358.3,40368,0)
+106 ;;=J44.1^^152^2010^12
+107 ;;^UTILITY(U,$J,358.3,40368,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,40368,1,3,0)
+110 ;;=3^COPD w/ Acute Exacerbation
+111 ;;^UTILITY(U,$J,358.3,40368,1,4,0)
+112 ;;=4^J44.1
+113 ;;^UTILITY(U,$J,358.3,40368,2)
+114 ;;=^5008240
+115 ;;^UTILITY(U,$J,358.3,40369,0)
+116 ;;=J42.^^152^2010^10
+117 ;;^UTILITY(U,$J,358.3,40369,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,40369,1,3,0)
+120 ;;=3^Bronchitis,Unspec Chronic
+121 ;;^UTILITY(U,$J,358.3,40369,1,4,0)
+122 ;;=4^J42.
